accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001437749-26-028111 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-08-17 | 8-K | fast_track | false | ex_1005774.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926028111/ex_1005774.htm |
0001193125-26-353278 | 1680581 | Fulcrum Therapeutics, Inc. | FULC | 2026-08-17 | 8-K | clinical_hold | true | d136791dex104.htm | https://www.sec.gov/Archives/edgar/data/1680581/000119312526353278/d136791dex104.htm |
0001193125-26-353308 | 1314102 | EyePoint, Inc. | EYPT | 2026-08-17 | 8-K | topline | false | eypt-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526353308/eypt-ex99_2.htm |
0001493152-26-038647 | 1853816 | Dermata Therapeutics, Inc. | null | 2026-08-17 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/ex10-1.htm |
0001493152-26-038649 | 1401914 | Dare Bioscience, Inc. | DARE | 2026-08-17 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1401914/000149315226038649/ex10-1.htm |
0001140361-26-033282 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-17 | 8-K | ind | false | ef20080234_ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126033282/ef20080234_ex1-1.htm |
0001493152-26-038437 | 1712762 | bioAffinity Technologies, Inc. | null | 2026-08-14 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1712762/000149315226038437/ex10-1.htm |
0001628280-26-056953 | 1411685 | Vistagen Therapeutics, Inc. | VTGN | 2026-08-14 | 8-K | topline | false | vtgn-20260814xex991.htm | https://www.sec.gov/Archives/edgar/data/1411685/000162828026056953/vtgn-20260814xex991.htm |
0001104659-26-096417 | 1346830 | Tvardi Therapeutics, Inc. | TVRD | 2026-08-14 | 8-K | topline | false | tm2623143d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1346830/000110465926096417/tm2623143d1_ex99-1.htm |
0001104659-26-096417 | 1346830 | Tvardi Therapeutics, Inc. | TVRD | 2026-08-14 | 8-K | ind | false | tm2623143d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1346830/000110465926096417/tm2623143d1_ex99-1.htm |
0001193125-26-350425 | 1498382 | TuHURA Biosciences, Inc./NV | HURA | 2026-08-14 | 8-K | orphan | false | hura-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1498382/000119312526350425/hura-ex99_1.htm |
0001104659-26-097226 | 1130598 | Traws Pharma, Inc. | TRAW | 2026-08-14 | 8-K | clinical_hold | true | tm2623190d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1130598/000110465926097226/tm2623190d1_ex99-1.htm |
0001628280-26-056966 | 1516551 | Skye Bioscience, Inc. | SKYE | 2026-08-14 | 8-K | topline | false | a260814_prxjointxskyexredx.htm | https://www.sec.gov/Archives/edgar/data/1516551/000162828026056966/a260814_prxjointxskyexredx.htm |
0001628280-26-056966 | 1516551 | Skye Bioscience, Inc. | SKYE | 2026-08-14 | 8-K | clinical_hold | true | projectsummit-transactiona.htm | https://www.sec.gov/Archives/edgar/data/1516551/000162828026056966/projectsummit-transactiona.htm |
0001628280-26-056966 | 1516551 | Skye Bioscience, Inc. | SKYE | 2026-08-14 | 8-K | fast_track | false | a260814_prxjointxskyexredx.htm | https://www.sec.gov/Archives/edgar/data/1516551/000162828026056966/a260814_prxjointxskyexredx.htm |
0001104659-26-097094 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-14 | 8-K | orphan | false | tm2623115d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926097094/tm2623115d1_ex99-1.htm |
0001193125-26-350568 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-08-14 | 8-K | topline | false | d163839dex991.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526350568/d163839dex991.htm |
0001193125-26-350445 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-08-14 | 8-K | fast_track | false | pmvp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526350445/pmvp-ex99_1.htm |
0001193125-26-350445 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-08-14 | 8-K | orphan | false | pmvp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526350445/pmvp-ex99_1.htm |
0001104659-26-096510 | 1649989 | Outlook Therapeutics, Inc. | OTLK | 2026-08-14 | 8-K | clinical_hold | true | tm2622399d2_ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1649989/000110465926096510/tm2622399d2_ex1-1.htm |
0001437749-26-027835 | 1659617 | Moleculin Biotech, Inc. | MBRX | 2026-08-14 | 8-K | interim | false | ex_1004839.htm | https://www.sec.gov/Archives/edgar/data/1659617/000143774926027835/ex_1004839.htm |
0001193125-26-352208 | 1620463 | LeonaBio, Inc. | LONA | 2026-08-14 | 8-K | topline | false | lona-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1620463/000119312526352208/lona-ex99_1.htm |
0001493152-26-037979 | 1763950 | Lantern Pharma Inc. | LTRN | 2026-08-14 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1763950/000149315226037979/ex99-1.htm |
0001493152-26-037979 | 1763950 | Lantern Pharma Inc. | LTRN | 2026-08-14 | 8-K | ind | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1763950/000149315226037979/ex99-1.htm |
0001140361-26-032946 | 1133416 | GALECTIN THERAPEUTICS INC | GALT | 2026-08-14 | 8-K | fast_track | false | ef20080011_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1133416/000114036126032946/ef20080011_ex99-1.htm |
0001193125-26-349936 | 1861123 | Eikon Therapeutics, Inc. | EIKN | 2026-08-14 | 8-K | interim | false | eikn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1861123/000119312526349936/eikn-ex99_1.htm |
0001213900-26-090181 | 1506251 | Citius Pharmaceuticals, Inc. | CTXR | 2026-08-14 | 8-K | orphan | false | ea030222701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1506251/000121390026090181/ea030222701ex99-1.htm |
0001213900-26-090182 | 1851484 | CITIUS ONCOLOGY, INC. | CTOR | 2026-08-14 | 8-K | orphan | false | ea030222601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1851484/000121390026090182/ea030222601ex99-1.htm |
0001104659-26-097180 | 1137883 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | 2026-08-14 | 8-K | orphan | false | tm2623188d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1137883/000110465926097180/tm2623188d1_ex99-1.htm |
0001104659-26-097091 | 1477845 | Annovis Bio, Inc. | ANVS | 2026-08-14 | 8-K | topline | false | tm2623272d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1477845/000110465926097091/tm2623272d1_ex99-1.htm |
0001213900-26-090183 | 1860657 | Allarity Therapeutics, Inc. | ALLR | 2026-08-14 | 8-K | fast_track | false | ea030215701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1860657/000121390026090183/ea030215701ex99-1.htm |
0001104659-26-095437 | 1953926 | Zenas BioPharma, Inc. | ZBIO | 2026-08-13 | 8-K | topline | false | tm2622871d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1953926/000110465926095437/tm2622871d1_ex99-1.htm |
0001104659-26-095437 | 1953926 | Zenas BioPharma, Inc. | ZBIO | 2026-08-13 | 8-K | endpoint_met | false | tm2622871d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1953926/000110465926095437/tm2622871d1_ex99-1.htm |
0001104659-26-095437 | 1953926 | Zenas BioPharma, Inc. | ZBIO | 2026-08-13 | 8-K | pdufa | false | tm2622871d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1953926/000110465926095437/tm2622871d1_ex99-1.htm |
0001104659-26-095925 | 1566044 | Yarrow Bioscience, Inc. | null | 2026-08-13 | 8-K | topline | false | tm2622598d1_ex99-8.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926095925/tm2622598d1_ex99-8.htm |
0001104659-26-095925 | 1566044 | Yarrow Bioscience, Inc. | null | 2026-08-13 | 8-K | fast_track | false | tm2622598d1_ex99-7.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926095925/tm2622598d1_ex99-7.htm |
0001104659-26-095925 | 1566044 | Yarrow Bioscience, Inc. | null | 2026-08-13 | 8-K | ind | false | tm2622598d1_ex99-4.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926095925/tm2622598d1_ex99-4.htm |
0001753926-26-001482 | 1266806 | Vivani Medical, Inc. | VANI | 2026-08-13 | 8-K | topline | false | ex991_1.htm | https://www.sec.gov/Archives/edgar/data/1266806/000175392626001482/ex991_1.htm |
0001193125-26-349334 | 1544227 | Tempest Therapeutics, Inc. | TPST | 2026-08-13 | 8-K | clinical_hold | true | d290418dex101.htm | https://www.sec.gov/Archives/edgar/data/1544227/000119312526349334/d290418dex101.htm |
0001178913-26-004122 | 2022416 | Silexion Therapeutics Corp | null | 2026-08-13 | 8-K | clinical_hold | true | exhibit_10-1.htm | https://www.sec.gov/Archives/edgar/data/2022416/000117891326004122/exhibit_10-1.htm |
0001708599-26-000048 | 1708599 | Serina Therapeutics, Inc. | SER | 2026-08-13 | 8-K | topline | false | ser-20260813xex991_earning.htm | https://www.sec.gov/Archives/edgar/data/1708599/000170859926000048/ser-20260813xex991_earning.htm |
0001193125-26-347854 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-08-13 | 8-K | ind | false | d150919d8k.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526347854/d150919d8k.htm |
0001193125-26-349157 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-13 | 8-K | topline | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526349157/rnxt-ex99_1.htm |
0001193125-26-349157 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-13 | 8-K | interim | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526349157/rnxt-ex99_1.htm |
0001193125-26-349157 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-13 | 8-K | orphan | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526349157/rnxt-ex99_1.htm |
0001193125-26-349157 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-13 | 8-K | ind | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526349157/rnxt-ex99_1.htm |
0001193125-26-347911 | 1782223 | Pyxis Oncology, Inc. | PYXS | 2026-08-13 | 8-K | fast_track | false | pyxs-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/pyxs-ex99_1.htm |
0001493152-26-037592 | 1574235 | Pulmatrix, Inc. | PULM | 2026-08-13 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1574235/000149315226037592/ex99-1.htm |
0001104659-26-095905 | 1374339 | ProMIS Neurosciences Inc. | PMN | 2026-08-13 | 8-K | topline | false | pmn-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1374339/000110465926095905/pmn-20260813xex99d1.htm |
0001104659-26-095905 | 1374339 | ProMIS Neurosciences Inc. | PMN | 2026-08-13 | 8-K | interim | false | pmn-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1374339/000110465926095905/pmn-20260813xex99d1.htm |
0001104659-26-095905 | 1374339 | ProMIS Neurosciences Inc. | PMN | 2026-08-13 | 8-K | fast_track | false | pmn-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1374339/000110465926095905/pmn-20260813xex99d1.htm |
0001829126-26-008773 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-13 | 8-K | topline | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008773/neonctechnologies_ex99-1.htm |
0001829126-26-008773 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-13 | 8-K | endpoint_met | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008773/neonctechnologies_ex99-1.htm |
0001829126-26-008773 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-13 | 8-K | interim | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008773/neonctechnologies_ex99-1.htm |
0001213900-26-089137 | 906709 | NEKTAR THERAPEUTICS | NKTR | 2026-08-13 | 8-K | topline | false | ea030192901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/906709/000121390026089137/ea030192901ex99-1.htm |
0001213900-26-089137 | 906709 | NEKTAR THERAPEUTICS | NKTR | 2026-08-13 | 8-K | fast_track | false | ea030192901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/906709/000121390026089137/ea030192901ex99-1.htm |
0001104659-26-095491 | 1735438 | MeiraGTx Holdings plc | MGTX | 2026-08-13 | 8-K | breakthrough | false | mgtx-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1735438/000110465926095491/mgtx-20260813xex99d1.htm |
0001193125-26-349490 | 1770069 | MapLight Therapeutics, Inc. | MPLT | 2026-08-13 | 8-K | topline | false | d48818dex991.htm | https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/d48818dex991.htm |
0001193125-26-349490 | 1770069 | MapLight Therapeutics, Inc. | MPLT | 2026-08-13 | 8-K | endpoint_met | false | d48818dex993.htm | https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/d48818dex993.htm |
0001193125-26-349490 | 1770069 | MapLight Therapeutics, Inc. | MPLT | 2026-08-13 | 8-K | endpoint_missed | true | d48818dex991.htm | https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/d48818dex991.htm |
0001193125-26-349490 | 1770069 | MapLight Therapeutics, Inc. | MPLT | 2026-08-13 | 8-K | fast_track | false | d48818dex991.htm | https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/d48818dex991.htm |
0001193125-26-349107 | 1468748 | Kodiak Sciences Inc. | KOD | 2026-08-13 | 8-K | topline | false | kod-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1468748/000119312526349107/kod-ex99_1.htm |
0001193125-26-347897 | 1503802 | Karyopharm Therapeutics Inc. | KPTI | 2026-08-13 | 8-K | topline | false | kpti-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1503802/000119312526347897/kpti-ex99_1.htm |
0001193125-26-347897 | 1503802 | Karyopharm Therapeutics Inc. | KPTI | 2026-08-13 | 8-K | endpoint_missed | true | kpti-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1503802/000119312526347897/kpti-ex99_1.htm |
0001193125-26-349141 | 921299 | KYNTRA BIO, INC. | KYNB | 2026-08-13 | 8-K | interim | false | kynb-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/921299/000119312526349141/kynb-ex99_1.htm |
0001193125-26-349193 | 1832038 | Invivyd, Inc. | IVVD | 2026-08-13 | 8-K | topline | false | ivvd-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1832038/000119312526349193/ivvd-ex99_1.htm |
0002007919-26-000044 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-08-13 | 8-K | topline | false | exhibit99106302026.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000044/exhibit99106302026.htm |
0002007919-26-000044 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-08-13 | 8-K | pdufa | false | exhibit99106302026.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000044/exhibit99106302026.htm |
0001437749-26-027667 | 811641 | IMMUCELL CORP /DE/ | ICCC | 2026-08-13 | 8-K | discontinue | true | ex_1004692.htm | https://www.sec.gov/Archives/edgar/data/811641/000143774926027667/ex_1004692.htm |
0001140361-26-032644 | 1444192 | Grace Therapeutics, Inc. | GRCE | 2026-08-13 | 8-K | crl | true | ef20079525_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1444192/000114036126032644/ef20079525_ex99-1.htm |
0001140361-26-032644 | 1444192 | Grace Therapeutics, Inc. | GRCE | 2026-08-13 | 8-K | orphan | false | ef20079525_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1444192/000114036126032644/ef20079525_ex99-1.htm |
0001193125-26-347984 | 1434316 | FATE THERAPEUTICS INC | FATE | 2026-08-13 | 8-K | ind | false | fate-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1434316/000119312526347984/fate-ex99_1.htm |
0001437749-26-027672 | 1710340 | Eton Pharmaceuticals, Inc. | ETON | 2026-08-13 | 8-K | fast_track | false | ex_974033.htm | https://www.sec.gov/Archives/edgar/data/1710340/000143774926027672/ex_974033.htm |
0001193125-26-349182 | 1746466 | Equillium, Inc. | EQ | 2026-08-13 | 8-K | topline | false | eq-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1746466/000119312526349182/eq-ex99_1.htm |
0001493152-26-037794 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-13 | 8-K | breakthrough | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226037794/ex99-1.htm |
0001493152-26-037794 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-13 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226037794/ex99-1.htm |
0001601485-26-000055 | 1601485 | Elicio Therapeutics, Inc. | ELTX | 2026-08-13 | 8-K | endpoint_missed | true | eltx2q26pr.htm | https://www.sec.gov/Archives/edgar/data/1601485/000160148526000055/eltx2q26pr.htm |
0001601485-26-000055 | 1601485 | Elicio Therapeutics, Inc. | ELTX | 2026-08-13 | 8-K | ind | false | eltx2q26pr.htm | https://www.sec.gov/Archives/edgar/data/1601485/000160148526000055/eltx2q26pr.htm |
0001193125-26-349154 | 1861123 | Eikon Therapeutics, Inc. | EIKN | 2026-08-13 | 8-K | interim | false | eikn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1861123/000119312526349154/eikn-ex99_1.htm |
0001193125-26-349154 | 1861123 | Eikon Therapeutics, Inc. | EIKN | 2026-08-13 | 8-K | ind | false | eikn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1861123/000119312526349154/eikn-ex99_1.htm |
0001104659-26-095512 | 1818844 | Dogwood Therapeutics, Inc. | DWTX | 2026-08-13 | 8-K | topline | false | dwtx-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1818844/000110465926095512/dwtx-20260813xex99d1.htm |
0001104659-26-095512 | 1818844 | Dogwood Therapeutics, Inc. | DWTX | 2026-08-13 | 8-K | fast_track | false | dwtx-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1818844/000110465926095512/dwtx-20260813xex99d1.htm |
0001493152-26-037737 | 1401914 | Dare Bioscience, Inc. | DARE | 2026-08-13 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1401914/000149315226037737/ex99-1.htm |
0001193125-26-347400 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-08-13 | 8-K | topline | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526347400/cgem-ex99_1.htm |
0001193125-26-347400 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-08-13 | 8-K | endpoint_met | false | cgem-20260812.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526347400/cgem-20260812.htm |
0001193125-26-347400 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-08-13 | 8-K | interim | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526347400/cgem-ex99_1.htm |
0001410098-26-000054 | 1410098 | CorMedix Inc. | CRMD | 2026-08-13 | 8-K | topline | false | crmd_q22026earningspr.htm | https://www.sec.gov/Archives/edgar/data/1410098/000141009826000054/crmd_q22026earningspr.htm |
0001493152-26-037605 | 1862150 | Cingulate Inc. | null | 2026-08-13 | 8-K | crl | true | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1862150/000149315226037605/ex99-1.htm |
0001493152-26-037605 | 1862150 | Cingulate Inc. | null | 2026-08-13 | 8-K | pdufa | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1862150/000149315226037605/ex99-1.htm |
0001750155-26-000116 | 1750155 | Charlotte's Web Holdings, Inc. | CWBHF | 2026-08-13 | 8-K | orphan | false | q22026earningspressrelease.htm | https://www.sec.gov/Archives/edgar/data/1750155/000175015526000116/q22026earningspressrelease.htm |
0001104659-26-095460 | 1279704 | Cellectar Biosciences, Inc. | CLRB | 2026-08-13 | 8-K | breakthrough | false | tm2623056d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1279704/000110465926095460/tm2623056d1_ex99-1.htm |
0001378325-26-000035 | 1378325 | CapsoVision, Inc | CV | 2026-08-13 | 8-K | clinical_hold | true | cv-20260813xex101.htm | https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813xex101.htm |
0001378325-26-000035 | 1378325 | CapsoVision, Inc | CV | 2026-08-13 | 8-K | ind | false | cv-20260813xex101.htm | https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813xex101.htm |
0001193125-26-347957 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-08-13 | 8-K | fast_track | false | cadl-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526347957/cadl-ex99_1.htm |
0001193125-26-347957 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-08-13 | 8-K | orphan | false | cadl-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526347957/cadl-ex99_1.htm |
0001193125-26-347957 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-08-13 | 8-K | ind | false | cadl-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526347957/cadl-ex99_1.htm |
0001213900-26-089147 | 1937993 | Cadrenal Therapeutics, Inc. | CVKD | 2026-08-13 | 8-K | fast_track | false | ea030204201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1937993/000121390026089147/ea030204201ex99-1.htm |
0001213900-26-089147 | 1937993 | Cadrenal Therapeutics, Inc. | CVKD | 2026-08-13 | 8-K | orphan | false | ea030204201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1937993/000121390026089147/ea030204201ex99-1.htm |
0001759138-26-000038 | 1759138 | Cabaletta Bio, Inc. | CABA | 2026-08-13 | 8-K | topline | false | caba-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1759138/000175913826000038/caba-ex99_1.htm |
0001759138-26-000038 | 1759138 | Cabaletta Bio, Inc. | CABA | 2026-08-13 | 8-K | endpoint_met | false | caba-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1759138/000175913826000038/caba-ex99_1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.